06-05-2024As syphilis rates continue to rise in the United States, emergency departments may be a way for people with limited healthcare access to get screening and treat…
06-05-2024Louis Shackelford of the HIV Vaccine Trials Network and NIH s Carl Dieffenbach discuss why a safe, effective, and durable HIV vaccine is important for ontroll..…
05-16-2024The STOMP trial is evaluating the antiviral drug tecovirimat (TPOXX) as a treatment for mpox. Learn how individuals, providers, and community organizations can.…
05-01-2024A quick roundup of key topics of HIV.gov’s coverage of the 2024 Conference on Retroviruses and Opportunistic Infections from HIV testing, treatment, and P…
04-24-2024While at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) last month, HIV.gov discussed an innovative syphilis screening program that is.…
04-12-2024In our latest FYI video, HIV community advocate Raif Derrazi shared his reflections on the 2024 Conference on Retroviruses and Opportunistic Infections (CROI)..…
03-06-2024On Tuesday at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), HIV.gov spoke with NIH s Dr. Carl Dieffenbach about research on common...
03-04-2024HIV.gov opened our coverage of the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) today with a conversation with Jeanne Marrazzo, M.D.,...
02-27-2024Next week, HIV.gov will be sharing updates on the latest HIV research from the 2024Conference on Retroviruses and Opportunistic Infections (CROI), taking...